Dose-Ranging Evaluation of Tesamorelin's Effects on Abdominal Fat in HIV Patients | RemedyX Labs Research Library

A research summary of A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation, examining dose-ranging evaluation of tesamorelin's effects on abdominal fat in hiv patients. Cited source and RUO context from RemedyX Labs.